ENSG vs EHC
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ENSG · Ensign$181.08 ▼ 0.72%
EHC · Encompass Health$137.54 ▼ 2.64%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ENSG -0.1%
- EHC +20.1%
Head to head
| Metric | ENSG | EHC |
|---|---|---|
| Price | $181.08 | $137.54 |
| Change today | ▼ 0.72% | ▼ 2.64% |
| Market cap | $10.56B | $13.50B |
| Return, 3 months | -1.5% | +9.3% |
| Return, year to date | +4.1% | +30.3% |
| Return, 1 year | +0.8% | +20.0% |
| P/E (TTM) | 26.9 | 21.5 |
| P/B | 4.1 | 5.0 |
| P/E percentile vs own 5y | 53rd | 52nd |
| Dividend yield | 0.14% | 0.57% |
| Revenue growth (YoY, latest qtr) | +14.5% | +9.6% |
| Net profit growth (YoY) | +24.4% | +12.2% |
| Gross margin | 16.6% | 95.8% |
| Operating margin | 9.0% | 18.0% |
| Net margin | 7.0% | 10.0% |
| Return on equity | 17.1% | 25.4% |
| Analyst target vs. price | +22.4% | +10.7% |
| Analyst buy share | 67% | 100% |
| RSI (14) | 53 | 64 |
| 30-day volatility | 37.4% | 38.6% |
| Max drawdown, 1 year | -31.8% | -26.1% |
| Trend read | Leaning bullish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- EHC is the largest of the group by market value.
- EHC has returned the most over the past year.
- EHC carries the lowest trailing P/E.
- EHC pays the highest dividend yield.
- ENSG is growing revenue fastest.
- EHC keeps the most profit per dollar of sales.
- ENSG has been the calmest stock over the last 30 days.